Autolus Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	104.13	227.38	239.57	382.44	310.34
Short-Term Investments	196.58	360.64	-	-	-
Cash & Short-Term Investments	300.71	588.02	239.57	382.44	310.34
Cash Growth	-48.86%	145.45%	-37.36%	23.23%	102.44%
Accounts Receivable	-	0.95	1.05	0.15	0.07
Other Receivables	-	47.3	23.5	28.82	26.18
Receivables	-	48.24	24.54	28.98	26.25
Inventory	-	4.14	-	-	-
Prepaid Expenses	-	15.21	8.64	12.34	8.71
Restricted Cash	-	1.43	0.77	0.33	0.34
Other Current Assets	135.21	3.89	1.79	1.7	1.31
Total Current Assets	435.92	660.93	275.3	425.77	346.95
Property, Plant & Equipment	-	105.05	95.65	58.42	52.32
Other Intangible Assets	-	12.37	-	-	0.07
Long-Term Deferred Tax Assets	-	3.24	3.06	2.08	1.83
Other Long-Term Assets	153.15	1.13	1.36	4.01	4.4
Total Assets	589.07	782.73	375.38	490.27	405.56
Accounts Payable	-	1.97	0.1	0.53	0.43
Accrued Expenses	-	51.8	39.05	40.4	23.51
Current Portion of Leases	-	3	5.05	5.04	4.45
Other Current Liabilities	73.44	3.98	0.53	0.39	0.16
Total Current Liabilities	73.44	60.74	44.74	46.37	28.55
Long-Term Debt	-	244.6	170.9	125.9	47.02
Long-Term Leases	-	49.63	47.91	19.22	16.55
Other Long-Term Liabilities	337.5	0.43	0.36	0.12	0.13
Total Liabilities	410.94	355.4	263.91	191.6	92.24
Common Stock	178.13	0.01	0.01	0.01	0
Additional Paid-In Capital	-	1,556	1,019	1,008	843.11
Retained Earnings	-	-1,099	-878.56	-670.18	-521.34
Comprehensive Income & Other	-	-29.06	-28.87	-38.78	-8.45
Shareholders' Equity	178.13	427.33	111.47	298.67	313.32
Total Liabilities & Equity	589.07	782.73	375.38	490.27	405.56
Total Debt	-	297.23	223.87	150.16	68.01
Net Cash (Debt)	300.71	290.79	15.7	232.28	242.32
Net Cash Growth	3.41%	1752.19%	-93.24%	-4.15%	144.43%
Net Cash Per Share	1.13	1.14	0.09	2.45	3.36
Filing Date Shares Outstanding	266.14	266.13	265.93	173.07	90.91
Total Common Shares Outstanding	266.14	266.12	174.1	173.07	90.91
Working Capital	362.48	600.19	230.57	379.41	318.4
Book Value Per Share	0.67	1.61	0.64	1.73	3.45
Tangible Book Value	178.13	414.95	111.47	298.67	313.26
Tangible Book Value Per Share	0.67	1.56	0.64	1.73	3.45
Machinery	-	50.42	38.37	35.98	38.92
Construction In Progress	-	19.64	12.54	13.19	2.44
Leasehold Improvements	-	14.12	12.73	11.69	14.9

Source: S&P Global Market Intelligence. Standard template. Financial Sources.